Search the Newsreel

Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss?

What Erie Indemnity (ERIE)'s Higher Q2 Results and Maintained Dividend Reveal About Its Capital Priorities

Tandem Diabetes Care (TNDM) Stock Jumps As Margin Recovery Steals The Spotlight

Tandem Diabetes Care's stock surged 19% after its Q2 earnings report, despite a net loss, due to a significant recovery in gross margin to 57%. Revenue grew 6%, and the net loss narrowed by 60%, with strong performance in international pump shipments and an …

Daily Brief Australia: Rio Tinto , EBOS Group , Academies Australasia, Adcorp Australia, AdVeritas , Airtasker, Alice Queen Ltd, Aldoro Resources Ltd, Alterity Therapeutics , Accelerate Resources Ltd and more

Tandem Diabetes Care, Inc. Stock 12‑Month Price Target Raised to $29.5, Implies 57% Upside

Analysts have raised the average 12-month price target for Tandem Diabetes Care, Inc. (TNDM) stock to $29.5, up from $29.19. This new target suggests a potential upside of approximately 57% from its August 6th closing price. The consensus rating among 22 analysts remains a …

Tandem Diabetes Care (NASDAQ:TNDM) Announces Earnings Results, Beats Estimates By $0.01 EPS

Tandem Diabetes Care Announces Second Quarter 2026 Financial Results

Tandem Diabetes Care, Inc. reported strong financial results for Q2 2026, with worldwide sales increasing 6% to $254.6 million and gross margin up 460 basis points to 57%. The company also highlighted strategic achievements, including FDA submissions for Tandem Mobi, expanded global technology solutions, …

Tandem Diabetes Care Inc (TNDM) News, Articles, Events & Latest Updates

Tandem Diabetes Care Inc (TNDM) reported Q2 2026 financial results, including a loss and lagging revenue estimates, despite some key metrics showing positive movement. The company announced upcoming conference presentations, product compatibility expansions, and plans to release Q2 results in August 2026. This news …

Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. published its Q2 2026 earnings call presentation, reporting an EPS of -$0.31, which beat estimates by $0.01. The company's revenue for the quarter was $254.56M, representing a 5.77% year-over-year increase, though it missed revenue expectations by $510.18K. The slide deck …

Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TNDM) 2026-08-07

Tandem Diabetes Care Q2 Earnings Call Highlights

Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Down - What's Next?

Tandem Diabetes Care (NASDAQ:TNDM) shares gapped down but later rose by 13.8%. Analyst ratings are mixed, with a consensus "Hold" and an average price target of $28.77, though Mizuho lowered its target to $20. The company reported an adjusted loss of $0.31 per share, …

Tandem Diabetes Care seeing early benefits of new pay-as-you-go model

Global Indemnity Group LLC (GBLI) Stock News Today

Tandem Diabetes Care (NASDAQ: TNDM) lifts Q2 sales to $254.6M, trims loss

Tandem Diabetes Care reported strong second-quarter 2026 results, with worldwide sales increasing by 6% to $254.6 million and a significant improvement in gross margin to 57%. The company also narrowed its GAAP net loss to $21.2 million and achieved positive Adjusted EBITDA of $6.4 …

Tandem Earnings: Few Surprises as the Firm Makes Progress With Mobi Pump

Global Indemnity Group (GBLI) Stock Rises On Underwriting Strength And Stubborn Costs

Global Indemnity Group (GBLI) saw its stock rise 4.8% after reporting Q2 2026 earnings that showed strong underlying underwriting profitability, with a combined ratio comfortably below 100%. Despite this, the company's expense ratio remains elevated as it continues to invest heavily in technology and …

Is Tandem Diabetes Care Inc (TNDM) a Value Opportunity After Q2 Earnings Miss? GF Score: 66/100

TANDEM DIABETES CARE INC 2026: Revenue $254.56M, EPS ($0.31) — 10-Q Summary

Tandem Diabetes Care Inc. (TNDM) reported its 2026 quarterly results, showing revenue of $254.56 million, an increase from $240.68 million in the previous year. The company significantly reduced its net loss to ($21.17 million) from ($52.4 million) year-over-year, with diluted loss per share narrowing …

Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say

Tandem Diabetes Q2 2026 slides: PayGo model drives margin expansion

Tandem Diabetes Care (NASDAQ:TNDM) reported record Q2 2026 sales of $255 million, despite a slight miss on revenue forecasts, driven by a strategic transition to a "PayGo" pharmacy-based reimbursement model. This new model is expected to more than double lifetime revenue per patient and …

Tandem Diabetes’s (NASDAQ:TNDM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

LSV Asset Management reports 5.16% stake in Academy Sports & Outdoors (ASO)

LSV Asset Management has reported a beneficial ownership of 5.16% in Academy Sports & Outdoors, Inc. (ASO) Class A common stock, totaling 3,202,955 shares as of June 30, 2026. The investment adviser holds sole voting power over 2,087,855 shares and sole dispositive power over …

Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) reported a Q2 loss of $0.31 per share, exceeding the Zacks Consensus Estimate of a $0.34 loss, marking an 8.82% surprise. Despite this, the company's Q2 revenues of $254.56 million missed the consensus estimate by 0.1%, leading to an …

Voya Financial (TNDM holder) discloses 149,088 Tandem Diabetes Care shares in 13G/A

Voya Financial, Inc. has filed an amended Schedule 13G/A, disclosing its beneficial ownership of 149,088 shares of Tandem Diabetes Care, Inc. common stock, which represents a 0.2% stake in the company. Voya Financial asserts sole voting and dispositive power over these shares. The filing …

Tandem’s Control-IQ+ Gets FDA Clearance for Type 1 Diabetes in Pregnancy

Is Academy Sports And Outdoors (ASO) Undervalued After Its Buy Rating And Retail Media Launch?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Academy Sports and Outdoors stock has delivered a 40.9% gain over the past five years, yet recent share price softness and a strong …

Global Indemnity Group, LLC Crushes Q2 2026 Profit Estimates by 20.6%

Transcript : Global Indemnity Group, LLC, Q2 2026 Earnings Call, Aug 05, 2026

This article provides the transcript of Global Indemnity Group, LLC's Q2 2026 earnings call, which took place on August 5, 2026. The call began with a message from the operator, but the rest of the transcript is reserved for subscribers. The page also lists …

Tandem Diabetes Care (TNDM) Rebounds On Growth Hopes, Is The Stock Still Undervalued?

Tandem Diabetes Care (TNDM) has seen a recent rebound in its stock price, with a 31% gain over 30 days, despite longer-term declines. The company is considered 30.8% undervalued with a fair value of $29.20 compared to its current $20.20, driven by expectations of …

Global Indemnity Group Q2 2026 Earnings Call Transcript

Global Indemnity Group (GBLI) reported strong Q2 2026 earnings with an accident-year combined ratio of 94.7% and $5.8 million in underwriting income. The company saw 7% year-over-year growth in Belmont Core gross written premiums and expects approximately 15% full-year premium growth, with investment income …

Earnings call transcript: Global Indemnity beats revenue in Q2 2026 as stock rises

Global Indemnity Group (GBLI) reported strong Q2 2026 earnings with an accident-year combined ratio of 94.7% and $5.8 million in underwriting income. The company saw 7% year-over-year growth in Belmont Core gross written premiums and expects approximately 15% full-year premium growth, with investment income …

ETFs Investing in Global Indemnity Group LLC Class A Stocks

This article lists ETFs that invest in Global Indemnity Group LLC Class A stocks. It provides a table showing funds, their market value, weight in the fund, issuer, management style, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV total return. The …

Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026

Global Indemnity Group, LLC reported increased net income for both the three and six months ended June 30, 2026, with quarterly net income rising 8% to $11.1 million, or $0.76 per share. The company saw a 7% growth in Belmont Core gross written premiums …

Tandem Diabetes earnings on deck as pharmacy shift tests execution

Tandem Diabetes Care Inc. is preparing to announce its second-quarter results, with analysts expecting a loss of 33 cents per share on revenue of $255.1 million. Investors are keenly focused on the company's transition from a traditional durable medical equipment model to a pay-as-you-go …

Global Indemnity Q2 Net Income Rises to $11.1 Million

Global Indemnity Group (GBLI) reported a rise in second-quarter net income to $11.1 million, or $0.76 per share, up from $10.3 million a year prior. Total revenues for the quarter were $116.1 million. The company also saw increased net income and diluted EPS for …